A Clinical Study to Test the Safety, Exposure, and Pharmacodynamic Markers of CSL311 in Patients With Mild-to-moderate Asthma and in Healthy Volunteers
Clinical trial NCT04082754 · COMPLETED
Trial details
- NCT number
- NCT04082754
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-28
- Primary completion
- 2023-11-14
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.